Remove Benchmarking Remove Biotech Remove Implementation
article thumbnail

Benchmarks 2023: How We’re Doing

Chief Executive

They were eye-opening, to say the least—and obviously a lot more than we could cram into an issue of the magazine—so we put the full results in a new study, Chief Executive Group’s 2022 Financial Benchmarks Report for U.S. A big contributing factor to this, of course, are the inflation-driven price increases companies are implementing.

article thumbnail

Match Your Innovation Process to the Results You Want

Harvard Business Review

We have a biotech client whose executive leadership team, starting with the CEO, demanded net present value estimates for fledgling, "beginning" ideas.and they wondered why they weren't launching any game-changing innovations. Breakthrough metrics and decision-making must be applied in totally opposite ways.

Metrics 16
article thumbnail

The Case Against Pay Transparency

Harvard Business Review

My colleague Tomasz Obloj, of HEC Paris, and I recently examined the effects of an awards program implemented at a European bank selling small consumer loans. As a result, some of these Harvard employees earned in excess of $30 million in yearly pay, due to performance that was truly exceptional against industry benchmarks.

Biotech 13